Citadel Advisors’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$647K Buy
35,725
+23,467
+191% +$425K ﹤0.01% 3764
2025
Q1
$117K Buy
+12,258
New +$117K ﹤0.01% 5096
2024
Q4
Sell
-12,720
Closed -$193K 5957
2024
Q3
$193K Sell
12,720
-26
-0.2% -$394 ﹤0.01% 4654
2024
Q2
$175K Buy
+12,746
New +$175K ﹤0.01% 4724
2024
Q1
Sell
-10,410
Closed -$102K 6087
2023
Q4
$102K Sell
10,410
-1,137
-10% -$11.2K ﹤0.01% 4866
2023
Q3
$123K Buy
11,547
+3,743
+48% +$39.8K ﹤0.01% 4755
2023
Q2
$108K Sell
7,804
-3,942
-34% -$54.4K ﹤0.01% 4714
2023
Q1
$118K Buy
11,746
+2,683
+30% +$27.1K ﹤0.01% 4848
2022
Q4
$141K Buy
9,063
+6,781
+297% +$106K ﹤0.01% 4858
2022
Q3
$45K Sell
2,282
-11,632
-84% -$229K ﹤0.01% 5350
2022
Q2
$351K Buy
13,914
+12,204
+714% +$308K ﹤0.01% 4479
2022
Q1
$42K Sell
1,710
-425
-20% -$10.4K ﹤0.01% 5960
2021
Q4
$60K Sell
2,135
-68,392
-97% -$1.92M ﹤0.01% 6101
2021
Q3
$2.95M Buy
70,527
+2,803
+4% +$117K ﹤0.01% 2575
2021
Q2
$3.15M Sell
67,724
-6,029
-8% -$281K ﹤0.01% 2686
2021
Q1
$4.07M Buy
73,753
+7,278
+11% +$402K ﹤0.01% 2341
2020
Q4
$4.83M Sell
66,475
-26,064
-28% -$1.89M ﹤0.01% 1802
2020
Q3
$18.3M Sell
92,539
-4,242
-4% -$837K 0.01% 787
2020
Q2
$27.1M Buy
96,781
+3,160
+3% +$884K 0.01% 626
2020
Q1
$16.7M Buy
93,621
+9,752
+12% +$1.74M 0.01% 737
2019
Q4
$20.6M Buy
83,869
+45,159
+117% +$11.1M 0.01% 784
2019
Q3
$4.57M Buy
38,710
+1,184
+3% +$140K ﹤0.01% 1733
2019
Q2
$6.08M Buy
37,526
+19,080
+103% +$3.09M ﹤0.01% 1512
2019
Q1
$4.36M Buy
18,446
+10,338
+128% +$2.44M ﹤0.01% 1684
2018
Q4
$2.2M Buy
+8,108
New +$2.2M ﹤0.01% 2121
2018
Q3
Sell
-1,772
Closed -$833K 4260
2018
Q2
$833K Buy
+1,772
New +$833K ﹤0.01% 2797
2018
Q1
Sell
-1,049
Closed -$569K 3963
2017
Q4
$569K Buy
+1,049
New +$569K ﹤0.01% 2732
2014
Q3
Sell
-234
Closed -$18K 3511
2014
Q2
$18K Sell
234
-1,269
-84% -$97.6K ﹤0.01% 3288
2014
Q1
$115K Buy
+1,503
New +$115K ﹤0.01% 3026